Xingtai Lesda TechnologyRetatrutide
Ordered Retatrutide from Xingtai Lesda Technology? Mail in a sample (US only) and let us test it for free.
Test my supplyOne severe Oct 2025 miss drives the caution: a 10 mg sample failed identity with 0 mg detected and 0% purity. Later passes rebuilt the score, but batch identifiers are often absent and no newer concrete COA appears.
We investigated who actually operates Xingtai Lesda Technology — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Xingtai Lesda Technology rows.
Cancel anytime
About Xingtai Lesda Technology test results from Finnrick
Xingtai Lesda Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 6 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Xingtai Lesda Technology peptides in this dataset are Retatrutide (6 tests), Tirzepatide (0 tests) and CJC-1295 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 6 recent tests.
Ordered Retatrutide from Xingtai Lesda Technology? Mail in a sample (US only) and let us test it for free.
Test my supply